In contrast, in a recent Cochrane meta-analysis comprising two high-quality RCTs, early EPO (initiated at age < 8 days) for preventing blood transfusion in preterm infants was related to a significantly increased risk of any grade ROP compared to late EPO (initiated at 8–28 days of age) [331]. This evidence concerns the gene EPO and retinopathy of prematurity.